Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/antibiotics9090569 http://scihub22266oqcxt.onion/10.3390/antibiotics9090569 32887358!7559022!32887358     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Antibiotics+(Basel) 2020 ; 9 (9): ä Nephropedia Template TP {{tp|p=32887358|t=2020. Mycogenic Metal Nanoparticles for the Treatment of Mycobacterioses |pdf=|usr=}}{{32887358}} gab.com Text Mycogenic Metal Nanoparticles for the Treatment of Mycobacterioses JO: Antibiotics (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=32887358 #FOAvip Mycobacterial infections are a resurgent and increasingly relevant problem. Within these, tuberculosis (TB) is particularly worrying as it is one of the top ten causes of death in the world and is the infectious disease that causes the highest number of deaths. A further concern is the on-going emergence of antimicrobial resistance, which seriously limits treatment. The COVID-19 pandemic has worsened current circumstances and future infections will be more incident. It is urgent to plan, draw solutions, and act to mitigate these issues, namely by exploring new approaches. The aims of this review are to showcase the extensive research and application of silver nanoparticles (AgNPs) and other metal nanoparticles (MNPs) as antimicrobial agents. We highlight the advantages of mycogenic synthesis, and report on their underexplored potential as agents in the fight against all mycobacterioses (non-tuberculous mycobacterial infections as well as TB). We propose further exploration of this field. Twit Text FOAVip Mycogenic Metal Nanoparticles for the Treatment of Mycobacterioses ????Antibiotics (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=32887358 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32887358 #FOAvip English Wikipedia <ref>{{Cite pmid|32887358}}</ref> Mycogenic Metal Nanoparticles for the Treatment of Mycobacterioses #MMPMID32887358 Simoes MF; Ottoni CA; Antunes A Antibiotics (Basel) 2020[Sep]; 9 (9): ä PMID32887358show ga Mycobacterial infections are a resurgent and increasingly relevant problem. Within these, tuberculosis (TB) is particularly worrying as it is one of the top ten causes of death in the world and is the infectious disease that causes the highest number of deaths. A further concern is the on-going emergence of antimicrobial resistance, which seriously limits treatment. The COVID-19 pandemic has worsened current circumstances and future infections will be more incident. It is urgent to plan, draw solutions, and act to mitigate these issues, namely by exploring new approaches. The aims of this review are to showcase the extensive research and application of silver nanoparticles (AgNPs) and other metal nanoparticles (MNPs) as antimicrobial agents. We highlight the advantages of mycogenic synthesis, and report on their underexplored potential as agents in the fight against all mycobacterioses (non-tuberculous mycobacterial infections as well as TB). We propose further exploration of this field. äMycogenic Metal Nanoparticles for the Treatment of Mycobacterioses (epmc).pdf DeepDyve Pubget Overpricing